Chemotherapy vs Hormone Therapy for Cancer

Chemotherapy works broadly against rapidly dividing cells and can reach cancer cells in different parts of the body. Hormone therapy changes or blocks hormone signals that help certain cancers grow. A treatment plan is based on the cancer's biology, location, stage, treatment goal, and the person's health and preferences.

Chemotherapy attacks rapidly dividing cells broadly, while hormone therapy slows cancers that depend on specific hormones; the treatments may sometimes be combined.

Chemotherapy may be considered when a broad treatment is needed, when the cancer is not hormone-sensitive, or when the tumour's behaviour calls for chemotherapy before or after surgery. It can also be used when cancer has spread and the team needs treatment that reaches several areas. The selected drugs depend on cancer type, previous treatment, and blood-count, kidney, liver, or nerve considerations.

Hormone therapy may be considered when testing shows that hormones help the cancer grow. It can be used after local treatment to reduce the chance of hormone stimulation, before another treatment, or when cancer has spread. The choice depends on the receptor result, menopausal or reproductive context when relevant, previous hormone medicines, and other health conditions.

Chemotherapy may cause tiredness, nausea, appetite changes, mouth soreness, hair loss, and changes in blood counts. Hormone therapy may cause hot flushes, sweating, sexual or reproductive changes, mood changes, joint symptoms, or bone effects, depending on the medicine. Some hormone medicines also need attention to blood clots, heart health, or other specific risks. Tell the care team about severe symptoms, fever, unusual bleeding, chest pain, or sudden shortness of breath.

Some cancers are treated mainly with surgery or radiotherapy, while others may call for immunotherapy, targeted therapy, or supportive care. A hormone receptor result may support hormone therapy without making it the only treatment. If the tumour does not depend on the relevant hormone signal, hormone therapy may not be useful, and the team will consider treatments matched to its other features.

Clinicians review the pathology report, including hormone receptor findings, cancer type, and stage. They then clarify whether the aim is to remove remaining cancer cells, control growth, ease symptoms, or prepare for surgery. Previous treatments, menstrual or reproductive status when relevant, bone health, clotting history, and other medicines can affect the choice. Ask whether hormone receptors were tested, why one treatment is being prioritised, how long the plan is expected to continue, and how side effects will be monitored.